Curasight accelerates the development of uTREAT

Curasight CEO: “Working on accelerated plan for uTREAT”

Looking back at the third quarter, it’s clear that Curasight is keeping the momentum in the development. Among other things, the much-anticipated phase II...
Proligt

Prolight’s CEO: ”Proof-of-Performance in whole blood important milestone” 

Prolight Diagnostics has demonstrated Proof-of-Performance in whole blood for its digital test system Psyros. It is already known that the system performs as promised...
Carlos de Sousa, CEO Ultimovacs

Ultimovacs CEO: “Data could put us at the forefront of cancer...

Ultimovacs has announced positive survival data from the phase II NIPU trial assessing the universal cancer vaccine UV1 in malignant mesothelioma. The company’s CEO...
Toleranzia rapporterar Q2

Scandions CMO: “Our overall survival data are quite impressive”

Scandion Oncologys läkemedelskandidat SCO-101 utvärderas för närvarande i fas II-studien CORIST för behandling av kemoterapiresistent metastaserad tjocktarmscancer. I veckan kunde bolaget meddela positiva data...

Saniona’s CEO: ”Selectivity is the cornerstone of future epilepsy treatments”

On Tuesday morning Saniona was able to announce advancements in its Kv7-programme. The company has now concluded the lead optimisation phase and the programme...
Cline Scientifics CEO convicted of market manipulation

Cline Scientific’s CEO convicted of market manipulation

Patrik Sundh, CEO and board member of Cline Scientific, has been convicted of market manipulation by the Stockholm District Court. This was announced by...
WntResearch reports Q3

WntResearch’s CEO: “In a better position than ever”

Reporting its third quarter, WntResearch is focusing on the restart of the NeoFox study with Foxy-5. The first patient was recently enrolled in the...
BIO-Europe

Busy days for Iconovo at BIO-Europe

Iconovo had three hectic days at BIO-Europe, with a large number of meetings with potential partners. The company especially highlighted their latest innovation, ICOone...
BIO-Europe

Lipum’s SOL-116 sparked interest at BIO-Europe 

On November 6-8, it was once again time for BIO-Europe, Europe's largest partnering conference in the life science sector. Lipum's CEO Einar Pontén and...
Toleranzia stegar på

Arcede proceeds to stability study in collaboration with Iconovo

Lund-based Arcede Pharma continues to advance its project with RCD405. The company recently concluded the toxicology program and has now announced that the collaboration...